Robert J. Bitterman - 14 Dec 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Interim Executive Chairman, Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
14 Dec 2022
Net transactions value
+$780
Form type
4
Filing time
15 Dec 2022, 16:00:30 UTC
Previous filing
08 Dec 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $780 +2,000 +2.8% $0.3900 74,541 14 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.